Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Heron Patrick J
Relationship:   Director, 10% Owner
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   33,453,667    

Indirect Shares

   27,246,926      
Direct Value   $768,465,650    

Indirect Value

   $166,134,654      
Total Shares   60,700,593      
Total Value   $934,600,303      


Anaptysbio Inc $23,142,757 Sierra Oncology Inc $446,085,534 Alpine Immune Sciences Inc $167,067,107 Aptinyx Inc. $306,248 Iterum Therapeutics Plc $10,357 Phathom Pharmaceuticals, Inc. $0 Entasis Therapeutics Holdings Inc. $2,846,897 Arcutis Biotherapeutics, Inc. $74,969 Tarsus Pharmaceuticals, Inc. $0 Frazier Lifesciences Acquisition Corp $0 Hillevax, Inc. $128,931,782 Anaptysbio Inc $23,142,757 Sierra Oncology Inc $446,085,534 Alpine Immune Sciences Inc $167,067,107 Aptinyx Inc. $306,248 Iterum Therapeutics Plc $10,357 Phathom Pharmaceuticals, Inc. $0 Entasis Therapeutics Holdings Inc. $2,846,897 Arcutis Biotherapeutics, Inc. $74,969 Tarsus Pharmaceuticals, Inc. $0 Frazier Lifesciences Acquisition Corp $0 Hillevax, Inc. $128,931,782
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    7   
    1    

     Stock price went up :
    2   
    0    
     Stock price went down :
    5   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   25.4%
 -59.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Trubion Pharmaceuticals, Inc TRBN 10% Owner Indirect, Di... 0 2010-10-28 0    Premium*  
            Cidara Therapeutics, Inc. CDTX Director 2015-04-20 0 2015-04-20 291,023    Premium*  
            Tobira Therapeutics Inc TBRA Director 2015-05-04 0 2015-05-04 2,668,570    Premium*  
            Collegium Pharmaceutical, Inc COLL Director, 10% Owner 2015-05-12 0 2015-05-12 1,887,332    Premium*  
            Anaptysbio Inc ANAB 10% Owner 2018-05-11 973,612 2018-05-11 973,612    Premium*  
            Sierra Oncology Inc SRRA 10% Owner 2017-02-14 8,112,121 0    Premium*  
            Alpine Immune Sciences Inc ALPN 10% Owner 2019-01-18 2,571,450 0    Premium*  
            Aptinyx Inc. APTX 10% Owner 2018-06-25 3,190,079 2018-06-25 0    Premium*  
            Iterum Therapeutics Plc ITRM Director 2020-07-01 9,006 2020-07-01 1,538,316    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM Director 2019-07-22 0 2023-11-09 3,728,875    Premium*  
            Phathom Pharmaceuticals, Inc. PHAT 10% Owner 2020-06-12 5,827,415 2020-06-12 31,446    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2020-01-09 1,299,953 2020-01-09 0    Premium*  
            Arcutis Biotherapeutics, Inc. ARQT 2024-03-04 8,687 2024-03-04 8,808,979    Premium*  
            Passage Bio, Inc. PASG Director, 10% Owner 2020-03-03 0 2020-03-03 5,009,219    Premium*  
            Vaxcyte, Inc. PCVX Director 2020-06-16 0 2020-06-16 2,309,554    Premium*  
            Tarsus Pharmaceuticals, Inc. TARS 10% Owner 2020-10-20 1,917,157 2020-10-20 0    Premium*  
            Frazier Lifesciences Acquisition... FLAC Director 2020-12-11 1,000,000 2020-12-11 0    Premium*  
            Hillevax, Inc. HLVX Director, 10% Owner 2024-04-04 8,544,187 2022-05-03 0    Premium*  
* Premium Members only  

Records found :    56         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
TRBN Trubion Pharmaceuticals, ... Director   –       •      –    2006-10-17 3 IO $0.00 $0 I/I 0 39,868 -
TRBN Trubion Pharmaceuticals, ... Director   –       •      –    2006-10-17 3/A IO $0.00 $0 I/I 0 105 -
TRBN Trubion Pharmaceuticals, ... Director   –       •      –    2006-10-23 4 A $0.00 $0 I/I 2,155,688 1,601,766 0 -
TRBN Trubion Pharmaceuticals, ... 10% Owner Indirect   –       •      –    2010-10-28 4 D $0.00 $0 I/I (2,237,940) 0 0 -
CDTX Cidara Therapeutics, Inc. Director   –       •      –    2015-04-20 4 B $16.00 $3,200,000 I/I 200,000 44,355 2.1 -
CDTX Cidara Therapeutics, Inc. Director   –       •      –    2015-04-20 4 A $0.00 $0 I/I 1,112,258 291,023 0 -
TBRA Tobira Therapeutics Inc Director   –       •      –    2015-05-04 4 A $0.00 $0 I/I 2,668,570 2,668,570 0 -
COLL Collegium Pharmaceutical,... Director   –       •       •   2015-05-12 4 B $12.00 $1,800,000 I/I 150,000 1,887,332 2.25 -
COLL Collegium Pharmaceutical,... Director   –       •       •   2015-05-12 4 A $0.00 $0 I/I 1,737,332 1,737,332 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 A $0.00 $0 D/D 2,228,377 195,751 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 A $0.00 $0 I/I 942,835 209,095 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 B $15.00 $6,000,000 I/I 400,000 88,709 1.5 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 B $15.00 $1,330,635 I/I 88,709 88,709 1.5 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 B $15.00 $4,669,365 D/D 311,291 311,291 2.45 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 A $0.00 $0 I/I 2,437,472 209,095 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-01-31 4 A $0.00 $0 D/D 733,740 733,740 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-02-02 4 OE $4.55 $533,419 I/I 117,235 2,345,612 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2017-02-02 4 OE $4.55 $533,419 D/D 117,235 2,345,612 0 -
SRRA Sierra Oncology Inc 10% Owner   –       –       •   2017-02-14 3 IO $0.00 $0 D/D 0 8,112,121 -
ALPN Alpine Immune Sciences In... 10% Owner   –       –       •   2017-07-24 3 IO $0.00 $0 D/D 0 2,199,011 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2018-05-11 4 D $0.00 $0 I/I (1,372,000) 973,612 0 -
ANAB Anaptysbio Inc 10% Owner   –       –       •   2018-05-11 4 D $0.00 $0 D/D (1,372,000) 973,612 0 -
APTX Aptinyx Inc. 10% Owner   –       –       •   2018-06-25 4 B $16.00 $2,400,000 D/D 150,000 3,190,079 2.45 -
APTX Aptinyx Inc. 10% Owner   –       –       •   2018-06-25 4 A $0.00 $0 D/D 3,040,079 3,040,079 0 -
ALPN Alpine Immune Sciences In... 10% Owner   –       –       •   2019-01-18 4 B $5.37 $1,999,997 D/D 372,439 2,571,450 2.45 -
  56  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us